Tuesday, March 17, 2026

GCCell Secures Groundbreaking Patent for Next-Gen Cell Therapy: What It Means for the Future of Immunotherapy

GC Cell has completed the registration of core technology patents for next-gen cell and gene therapies in South Korea and Japan.

H&M’s Collaboration with Korean Designer Brand Rokh Sells Out in Hours

H&M's collaboration with Korean designer brand Rokh...

Android 16 to Launch Built-In Intrusion Detection System

Android 16 will introduce a new Intrusion Detection System for enhanced security, storing encrypted logs of activities in Google Drive.

Tag: cancer

Celltrion’s Breakthrough: Why Vegzelma and Herzuma Lead in Japan’s Oncology Market

Celltrion's cancer treatments dominate the Japanese market, with Vegzelma and Herzuma capturing significant shares, showcasing strong growth.

Celltrion’s Ramucirumab and Infliximab: The Secrets Behind Their Dominance in Oceania’s Biopharmaceutical Market

Celltrion's cancer and autoimmune products are expanding market share in Australia and New Zealand, enhancing influence in Oceania.

How Celltrion’s Herceptin Biosimilar Herzuma Achieved 74% Market Share in Japan: A Game Changer for Cancer Treatment

Celltrion's Herzuma biosimilar captures 74% of Japan's trastuzumab market, enhancing patient access and leveraging favorable policies.

How Keytruda is Revolutionizing Cancer Treatment: Expanded Coverage for Stomach Cancer in 2026

Keytruda's insurance coverage expands to stomach cancer, solidifying its status as a leading universal immunotherapy for various cancers.

2026 Breakthrough in Stomach Cancer: How Proximal Gastrectomy Enhances Quality of Life

Professor Kim Hyung-il's study shows proximal gastrectomy's effectiveness for early-stage stomach cancer, enhancing patient quality of life.

Why Samsung Medical Center is Now Korea’s Top Hospital: A Deep Dive into the 2026 Rankings

Samsung Medical Center ranks as South Korea's top hospital and 26th globally in Newsweek's World's Best Hospitals 2026 list.

Northwell Health Partners with Rokit Healthcare: What This Means for Skin Cancer Treatment in 2026

Northwell Health partners with Rokit Healthcare to advance skin cancer regeneration and wound healing technologies in the U.S. market.

Why Centrum Multivitamins Are Backed by 32 Clinical Studies: A Deep Dive into Their Proven Benefits

Centrum multivitamins stand out for their extensive research backing, showing benefits in cancer risk reduction and cognitive function.

World Cancer Day 2026: How Patient-Centered Care is Transforming Cancer Treatment in Asia

The National Cancer Center joins a global campaign for World Cancer Day, promoting People-Centered Care through dialogue with patients.

GCC2005: The Breakthrough CAR-NK Therapy for T-Cell Lymphoma Unveiled at TCLF 2026

GC Cell presents promising CD5-targeting CAR-NK therapy GCC2005 for T-cell lymphoma, showing significant efficacy and safety at TCLF.

Celltrion’s Remsima SC: The Leading Autoimmune Drug with 68% Market Share in Europe

Celltrion's treatments for autoimmune diseases and cancer maintain strong market positions in Europe, bolstered by stable prescriptions and new products.

Male Breast Cancer Has More Than Doubled in 16 Years—So Why Haven’t Survival Rates Improved?

A study shows male breast cancer cases have doubled in 16 years, but survival rates remain low, highlighting treatment disparities.

Revolutionary mRNA Cancer Treatment Shows 49% Survival Improvement: What You Need to Know

A study shows mRNA-based cancer treatments significantly improve survival rates, marking a breakthrough in precision therapy for melanoma.

2023 Cancer Statistics: Prostate Cancer Surges to Top Spot Among Men in Korea

Prostate cancer is now the most common cancer in South Korean men, reflecting demographic shifts and improved survival rates.

Top News

- Our Sponsors Ad -

Follow us